PubMed Health⌕ Search

Biomedical subjects

Georg Bongartz

Publications and source records attributed to Georg Bongartz.

16 recordsLinked to original sources
PubMed2006

Intraarterial MR angiography and DSA in patients with peripheral arterial occlusive disease: prospective comparison.

PURPOSE: To prospectively evaluate the accuracy of intraarterial magnetic resonance (MR) angiography in the depiction of significant stenoses and occlusions, with intraarterial digital subtraction angiography (DSA) serving as the reference standard. MATERIALS AND METHODS: Approval of the local ethics committee and informed consent were obtained. Twenty patients (11 men; nine women; age range, 48-86 years; mean age, 69.5 years+/-11.2 [standard deviation]) with symptomatic peripheral arterial occlusive disease (PAOD) were prospectively enrolled. After percutaneous transluminal angioplasty (PTA), intraarterial MR angiography was performed in the thigh and the calf with a 1.5-T MR imager in two consecutive runs. Intraarterial MR angiography was performed with a low-dose injection protocol (ie, two 20-mL injections of a 50-mmol gadolinium-based contrast agent). Moderate stenoses (luminal narrowing 50%) or vessel occlusions; 95% confidence intervals (CIs) were calculated for sensitivity and specificity. RESULTS: Intraarterial DSA revealed 78 moderate stenoses, 57 significant stenoses, and 28 occlusions. Sensitivity, specificity, and accuracy of intraarterial MR angiography in the characterization of significant stenoses or occlusions were 92% (95% CI: 72%, 99%), 94% (95% CI: 82%, 98%), and 93%, respectively, in femoropopliteal arteries and 93% (95% CI: 83%, 98%), 71% (95% CI: 51%, 86%), and 86%, respectively, in infrapopliteal arteries. The main artifact observed with intraarterial MR angiography was venous contamination (12%). CONCLUSION: Intraarterial MR angiography is an accurate method used to depict significant stenoses and occlusions in lower extremity arteries with a low-dose injection protocol.

Aged↗
PubMed2006

Coronary artery imaging with contrast-enhanced MDCT: extracardiac findings.

OBJECTIVE: The purpose of our study was to evaluate the incidence of extracardiac findings on contrast-enhanced MDCT of the coronary arteries and to assess the effect of different field-of-view settings. SUBJECTS AND METHODS: Patients with suspected coronary artery disease (n = 166) were examined with contrast-enhanced MDCT (16 x 0.75 mm focused on the heart) during injection of contrast material (80 mL injected at a rate of 4 mL/sec) followed by saline (20 mL injected at 4 mL/sec). Retrospectively gated images were reconstructed at a 1-mm slice thickness and a 0.5-mm increment with isotropic voxels of 1 mm3. Images were reviewed for extracardiac findings, which were then classified as none, minor, or major with respect to their impact on patient management and treatment. In a different group of patients (n = 20), chest scans (16 x 1.5 mm) were used for measuring volumes of displayed body structures on wholechest scans, coronary artery MDCT images, and coronary artery MDCT images reconstructed with the maximum field of view. RESULTS: Extracardiac findings were detected in 41 patients (24.7%). Findings were classified as minor (19.9%) or major (4.8%). Among the major findings, which had an immediate impact on patient management and treatment, were bronchial carcinoma and pulmonary emboli. Volume analysis revealed that 35.5% of the total chest volume was displayed on dedicated coronary artery MDCT focused on the heart, whereas 70.3% of the chest was visible when coronary artery MDCT raw data were reconstructed with the maximal field of view (p < 0.001). CONCLUSION: Coronary artery MDCT can reveal important findings and disease in extracardiac structures. Thus, the entire examination should be reconstructed with the maximum field of view and should be reviewed by a qualified radiologist.

Adult↗
PubMed2006

MR angiography of the hand with subsystolic cuff-compression optimization of injection parameters.

OBJECTIVE: The purpose of our study was to assess the impact of various injection rates on contrast-enhanced high-resolution 3D MR angiography of the hand. MATERIALS AND METHODS: Ten healthy individuals (mean age, 24.4 years; range, 20-27 years) underwent 3D contrast-enhanced MR angiography of both hands. Starting 3 minutes before data acquisition, subsystolic upper arm cuff compression was applied unilaterally. A 1.5-T whole-body scanner with 3D gradient-echo sequence was used. Seven data sets (20 seconds) were obtained consecutively. I.v. contrast material of 0.1 mg/kg of body weight of gadobutrol was injected at rates of 0.5, 1.0, and 1.5 mL/s. For both hands, quantitative data evaluation was performed with contrast-to-noise ratio (CNR) in the radial, ulnar, palmar, and digital arteries and veins. Qualitative assessment of the arterial visualization score and venous contamination score was rated by two experienced radiologists using a 4-point scale. RESULTS: The lowest venous contamination score (CNR and reviewers' assessment) was observed with an injection rate of 0.5 mL/s (p < 0.05). For the arterial signal, the reviewers' assessment was that an injection rate of 0.5 mL/s was best (p = 0.08). Compression yielded a significantly lower venous contamination score for the compressed side than for the noncompressed side for flow rates of 0.5 mL/s and 1.0 mL/s (p < 0.05). CONCLUSION: Image quality of hand MR angiography was better with cuff compression. A flow rate of 0.5 mL/s yielded a good CNR and a significantly lower venous contamination score than the other flow rates.

Adult↗
PubMed2005

Limited diagnostic yield of non-invasive coronary angiography by 16-slice multi-detector spiral computed tomography in routine patients referred for evaluation of coronary artery disease.

AIMS: Multislice spiral computed tomography (MSCT) is a promising non-invasive method to diagnose coronary artery disease (CAD). As no detailed comparative evaluation in consecutive patients referred for evaluation of CAD has been reported, this prospective study evaluating 2384 coronary segments in 149 consecutive patients was performed. METHODS AND RESULTS: The coronary artery tree was analysed in 16 segments both for coronary angiography (CA) and MSCT; a luminal narrowing > or = 50% based on visual assessment was considered significant. By MSCT, 77% of 2110 angiographically assessable segments could be evaluated, 94% per patient in proximal and 70% in distal segments (P<0.001). Sensitivity of MSCT to detect significant stenoses was 30% in all, but only 10% in peripheral segments. The main limitations were calcifications in 34% of segments and motion artefacts in 24% of patients. Overall diagnostic sensitivity for the presence of significant CAD was 86% but specificity was only 49%. CONCLUSION: When compared with invasive CA, 16-slice MSCT is of limited diagnostic value for the diagnosis of CAD in consecutive patients. Despite a clinically useful sensitivity for the overall diagnosis of significant CAD, specificity is low. Thus, relevant decisions regarding the need of and suitability for possible revascularization procedures cannot be based on MSCT findings alone.

Coronary Angiography↗
PubMed2005

Image quality from high-resolution CT of the lung: comparison of axial scans and of sections reconstructed from volumetric data acquired using MDCT.

OBJECTIVE: Our objective was to compare the image quality of reconstructed thin sections obtained from a 16-MDCT scanner with that of axial high-resolution CT scans of the same patient. SUBJECTS AND METHODS: Fifty consecutive patients referred for CT of the chest underwent 16-MDCT and, subsequently, axial high-resolution CT. The volumetric raw data from the MDCT scans were reconstructed into slices 2-mm thick using a high-spatial-frequency reconstruction algorithm. Two blinded reviewers independently rated the images from both methods for subjective image-quality criteria. The results were tested for statistical significance using Wilcoxon's signed rank test, and p values of less than 0.05 were considered significant. The effective dose for axial high-resolution CT and volumetric MDCT was calculated. RESULTS: Motion artifacts were significantly more common on high-resolution CT scans than on reconstructed thin-section images (p < 0.001). The two methods differed significantly in lung attenuation (p = 0.008), mainly because of the presence of ground-glass opacities. The assessment of ground-glass attenuation was superior on axial high-resolution CT. The effective doses were 3.8 mSv for MDCT and 0.9 mSv for high-resolution CT. CONCLUSION: Reconstructed high-resolution images generated from a single MDCT data acquisition are of comparable quality to images obtained using conventional axial high-resolution CT. However, contiguous MDCT is not recommended for diseases showing predominantly ground-glass patterns, because axial high-resolution CT delineates ground-glass attenuation significantly better.

Adult↗
PubMed2005

Intraarterial versus IV gadolinium injections for MR angiography: quantitative and qualitative assessment of the infrainguinal arteries.

OBJECTIVE: Our purpose was to quantitatively and qualitatively compare 3D intraarterial (IA) gadolinium-enhanced MR angiography (IA MRA) versus the standard of reference of MR angiography, 3D IV gadolinium-enhanced MR angiography (IV MRA), in patients with peripheral arterial occlusive disease (PAOD) for use during catheter-based MR-guided endovascular interventions. CONCLUSION: IA MRA provides image quality of the infrainguinal arteries in PAOD patients comparable to IV MRA with a significantly improved assessment of the infrapopliteal arteries due to reduced venous contamination. Further benefits of IA MRA include usage of only very low doses of gadolinium and simplified bolus timing.

Aged↗
PubMed2004

Lower extremity: low-dose contrast agent intraarterial MR angiography in patients--initial results.

Institutional review board approval and patient consent were obtained. A low-dose injection protocol for intraarterial three-dimensional (3D) gadolinium-enhanced magnetic resonance (MR) angiography was derived from femoral flow phantom studies and prospectively evaluated in patients with peripheral arterial occlusive disease (PAOD). All MR angiograms were obtained at 1.5 T with a T1-weighted gradient-echo sequence. MR angiograms of a gadolinium dilution series (0.8-200.0 mmol/L) were acquired in a femoral phantom at different flow rates. Signal-to-noise ratios (SNRs) above the 75% threshold of the measured maximum were considered optimal. The lowest optimal concentration was injected intraarterially in nine patients to obtain 3D MR angiograms of the thigh and calf station. Contrast-to-noise ratios (CNRs) were calculated for four arterial segments. The low optimal concentration of 50 mmol/L (20-mL bolus volume), about 5% of the total permissible dose, showed SNRs larger than the 75% threshold in the phantom study. In patients, this concentration led to high-spatial-resolution angiograms with mean CNRs of 70.0 +/- 14.5 (+/- standard deviation) for the superficial femoral artery and 47.5 +/- 13.4 at the infrapopliteal level. Low-dose contrast agent intraarterial 3D MR angiography showed high arterial enhancement, enabling assessment of lower extremity arteries in patients with PAOD and multiple injections--a crucial precondition for MR-guided endovascular interventions.

Aged↗
PubMed2004

Infragenual cuff-compression reduces venous contamination in contrast-enhanced MR angiography of the calf.

PURPOSE: To reduce venous contamination at the calf level in three-dimensional contrast-enhanced MR angiography (CE-MRA) by applying continuous infragenual cuff-compression. MATERIALS AND METHODS: Ten patients with clinically relevant peripheral arterial occlusive disease (PAOD) underwent dynamic three-dimensional CE-MRA of the calf. Six consecutive measurements were acquired with the first measurement serving as mask. Cuff-compression of 50 mmHg was attached below the knee. To allow intra-individual comparison, compression was applied unilaterally. The cuff was inflated three minutes before scanning and was continued throughout the MRA session. Venous contamination and arterial visualization scores were ranked using a five-point rating scale. Contrast-to-noise ratios (CNRs) of superficial enhancing calf-veins on the uncompressed and compressed calf sides were evaluated. An asymmetry index (AI) defined by CNR(mean) (uncompressed)/CNR(mean) (compressed) was introduced to describe the ratio in venous contrast agent supply between both sides quantitatively. RESULTS: Three-dimensional CE-MRA of the calves demonstrated significantly lower superficial venous contamination scores (P < 0.004) and clearly improved arterial visualization (P < 0.009) on the compressed side. Additionally, AI values were larger than 1 (P < 0.02), indicating a higher contrast agent supply in the superficial veins on the uncompressed side. CONCLUSION: Infragenual cuff-compression minimizes venous overlay in three-dimensional CE-MRA at calf level by reduction of contrast agent supply in the superficial veins.

Aged↗
PubMed2004

MRI characteristics of olecranon bursitis.

OBJECTIVE: Our aim was to describe the MRI characteristics of septic and nonseptic olecranon bursitis. MATERIALS AND METHODS: MRI contrast-enhanced examinations (n = 19) of 35 patients with olecranon bursitis (septic, n = 14; nonseptic, n = 21) were jointly reviewed by two musculoskeletal radiologists. We evaluated bursa size, extent of marginal lobulation, septation, concomitant elbow joint effusion, soft-tissue edema, rim enhancement, soft-tissue enhancement, degree of fluid complexity, definition of bursa margins, presence of edema, thickening of the triceps tendon, and bone marrow edema. RESULTS: Comparison of septic and nonseptic bursitis yielded the following results: marginal lobulation, 79% (11/14) versus 48% (10/21), p = 0.14; bursa septation, 64% (9/14) versus 57% (12/21), p = 1.0; moderate or marked complexity of bursa fluid, 64% (9/14) versus 29% (6/21), p = 0.15; poorly defined margins, 64% (9/14) versus 67% (14/21), p = 1.0; elbow joint effusion, 86% (12/14) versus 52% (11/21), p = 0.12; moderate to marked soft-tissue edema, 64% (9/14) versus 33% (7/21), p = 0.1; edema of the triceps, 57% (8/14) versus 48% (10/21), p = 0.73; thickening of the triceps, 43% (6/14) versus 14% (3/21), p = 0.21; bone marrow edema, 29% (4/14) versus 5% (1/21), p = 0.13; rim enhancement, 100% (11/11) versus 75% (6/8), p = 0.31; soft-tissue enhancement, 100% (11/11) versus 63% (5/8), p = 0.1. CONCLUSION: Septic and nonseptic olecranon bursitis present with a considerable overlap of MRI findings without statistically significant differences. Septic olecranon bursitis can be excluded in the absence of bursal and soft-tissue enhancement.

Bursa, Synovial↗
PubMed2003

Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography.

The aim of this study was to test the safety and efficacy of NC100150 injection for steady-state contrast-enhanced peripheral MR angiography in a multicentre phase-II trial. Thirty-three patients underwent steady-state NC100150 enhanced MR angiography (5 mg Fe/kg body weight) of the aortoiliac and femoropopliteal arteries. Safety assessment consisted of pre- and post-injection (2, 24 and 72 h) monitoring of vital signs, physical examination as well as laboratory and electrocardiographic parameters. To determine sensitivity and specificity for detection of haemodynamically significant stenoses (HSS; >50% reduction of luminal diameter) MR angiograms were compared with intra-arterial digital subtraction angiography (IA DSA), which was considered the standard of reference. In 33 patients a mean of 12.8 ml NC100150 was injected. Eleven patients reported 13 mild and 2 moderate adverse events. Five mild and one moderate adverse event were considered due to NC100150 injection. There were no significant changes in vital signs, laboratory or electrocardiographic parameters. Sensitivity and specificity (in percent) for detection of HSS were 87 and 64, 56 and 76, and 75 and 84, for iliac, femoral and popliteal arteries, respectively. NC100150 high-resolution steady-state MR angiography can be performed safely and is feasible for the detection of peripheral arterial HSS, but is as yet not a clinically useful alternative to conventional gadolinium-enhanced MR angiography.

Angiography, Digital Subtraction↗
PubMed2003

Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a potentially fatal disease, which is often difficult to diagnose. As a non-invasive test cardiac magnetic resonance imaging (CMR) has become an important tool in establishing the diagnosis. The aim of this study was to evaluate the diagnostic and prognostic value of CMR in patients with suspected ARVC and to assess the long-term outcome of patients with CMR-diagnosed ARVC. Thirty-six patients with suspected ARVC (26 male, 10 female, median age 41 years) underwent non-invasive and invasive clinical tests as gold standard for ARVC diagnosis. ARVC was clinically diagnosed in 19 patients and excluded in 17 patients. Both groups underwent CMR, and diagnosis was confirmed by CMR in 16/18 patients with clinically diagnosed ARVC (sensitivity 89%), and correctly excluded in 14/17 of patients with clinically excluded ARVC (specificity 82%). This result indicates a positive predictive value of the CMR of 84%, and a negative predictive value of 88%, respectively (p < 0.0001). Using a scoring system, multiple CMR parameters were compared in the two groups in regard of the clinical diagnosis. By univariate analysis, right ventricular fatty tissue infiltration (p = 0.0003) was predictive for diagnosis. Compared by outcome, 37% of patients with clinically and by CMR-diagnosed ARVC had an arrhythmic event during a mean follow-up of 16 +/- 11 months. These data suggest that CMR is a highly sensitive and specific method to diagnose or exclude ARVC, and thus, has an important prognostic impact on predicting arrhythmia free survival.

Adult↗
PubMed2003

Dose optimization for dynamic time-resolved contrast-enhanced 3D MR angiography of pulmonary circulation.

OBJECTIVE: The aim of this study was to optimize contrast media dose for assessment of pulmonary circulation with dynamic time-resolved contrast-enhanced 3D MR angiography. SUBJECTS AND METHODS. Twenty healthy volunteers (20-38 years old; mean [+/- SD], 27.2 +/- 4.5 years) were examined prospectively using turbo fast low-angle shot MR angiography (TR/TE, 2.4/1.04). Ten consecutive coronal 3D slabs with a frame rate of 3.2-sec duration were acquired during injection of contrast media at a rate of 4 mL/sec. Signal intensities were measured in various vessels and pulmonary parenchyma. Maximum signal-intensity enhancement (DeltaSI(max)) and time to peak enhancement were calculated. Depiction of pulmonary vessels and pulmonary parenchyma was scored according to an image quality score. RESULTS: Central pulmonary arteries were well visualized at all tested doses. Segmental arteries, however, were blurry with 0.025 or 0.05 mmol/kg; image quality was improved at 0.1 mmol/kg of gadoterate meglumine (p < 0.05). Image quality did not further improve at 0.2 mmol/kg (p = not significant). Values for DeltaSI(max) in the pulmonary trunk were 38.9 +/- 9.7, 64.1 +/- 9.1, 79.7 +/- 12.2, and 96 +/- 6.0 at 0.025, 0.5, 0.1, and 0.2 mmol/kg of gadoterate meglumine, respectively. Pulmonary parenchyma showed almost no enhancement at 0.025 and 0.5 mmol/kg of gadoterate meglumine (DeltaSI(max) = 1.6 +/- 1.1 and 1.6 +/- 1.2, respectively), but better visualization was shown with 0.1 and 0.2 mmol/kg of gadoterate meglumine (DeltaSI(max) = 2.9 +/- 0.8 and 6.7 +/- 2.1, respectively). Time from peak enhancement in pulmonary arteries to peak enhancement in veins was independent of dose. CONCLUSION: A dose of 0.1 mmol/kg of gadolinium chelate allows depiction of pulmonary arteries and qualitative assessment of pulmonary parenchyma. Thus, 0.1 mmol/kg can be recommended for dynamic contrast-enhanced 3D MR angiography.

Adult↗